|
1
|
Oh JK and Weiderpass E: Infection and
cancer: Global distribution and burden of diseases. Ann Glob
Health. 80:384–392. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Arbyn M, Castellsagué X, de Sanjosé S,
Bruni L, Saraiya M, Bray F and Ferlay J: Worldwide burden of
cervical cancer in 2008. Ann Oncol. 22:2675–2686. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vaccarella S, Laversanne M, Ferlay J and
Bray F: Cervical cancer in Africa, Latin America and the Caribbean
and Asia: Regional inequalities and changing trends. Int J Cancer.
Jul 22–2017.(Epub ahead of print). View Article : Google Scholar
|
|
4
|
Nayir T, Okyay RA, Nazlican E, Yesilyurt
H, Akbaba M, Ilhan B and Kemik A: Cervical cancer screening in an
early diagnosis and screening center in mersin, Turkey. Asian Pac J
Cancer Prev. 16:6909–6912. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
zur Hansen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bzhalava D, Eklund C and Dillner J:
International standardization and classification of human
papillomavirus types. Virology. 476:341–344. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arbyn M, Tommasino M, Depuydt C and
Dillner J: Are 20 human papillomavirus types causing cervical
cancer? J Pathol. 234:431–435. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Doorbar J, Egawa N, Griffin H, Kranjec C
and Murakami I: Human papillomavirus molecular biology and disease
association. Rev Med Virol. 25 Suppl 1:S2–S23. 2015. View Article : Google Scholar
|
|
10
|
de Sanjose S, Quint WG, Alemany L, Geraets
DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin
HR, et al: Human papillomavirus genotype attribution in invasive
cervical cancer: A retrospective cross-sectional worldwide study.
Lancet Oncol. 11:1048–1056. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Smith JS, Lindsay L, Hoots B, Keys J,
Franceschi S, Winer R and Clifford GM: Human papillomavirus type
distribution in invasive cervical cancer and high-grade cervical
lesions: A meta-analysis update. Int J Cancer. 121:621–632. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Onuki M, Matsumoto K, Satoh T, Oki A,
Okada S, Minaguchi T, Ochi H, Nakao S, Someya K, Yamada N, et al:
Human papillomavirus infections among Japanese women: Age-related
prevalence and type-specific risk for cervical cancer. Cancer Sci.
100:1312–1316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li N, Franceschi S, Howell-Jones R,
Snijders PJ and Clifford GM: Human papillomavirus type distribution
in 30,848 invasive cervical cancers worldwide: Variation by
geographical region, histological type and year of publication. Int
J Cancer. 128:927–935. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Azuma Y, Kusumoto-Matsuo R, Takeuchi F,
Uenoyama A, Kondo K, Tsunoda H, Nagasaka K, Kawana K, Morisada T,
Iwata T, et al: Human papillomavirus genotype distribution in
cervical intraepithelial neoplasia grade 2/3 and invasive cervical
cancer in Japanese women. Jpn J Clin Oncol. 44:910–917. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chan PK, Ho WC, Chan MC, Wong MC, Yeung
AC, Chor JS and Hui M: Meta-analysis on prevalence and attribution
of human papillomavirus types 52 and 58 in cervical neoplasia
worldwide. PLoS One. 9:e1075732014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Graham SV: Human Papillomavirus E2
Protein: Linking replication, transcription and RNA processing. J
Virol. 90:8384–8388. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chaiwongkot A, Vinokurova S, Pientong C,
Ekalaksananan T, Kongyingyoes B, Kleebkaow P, Chumworathayi B,
Patarapadungkit N, Reuschenbach M and von Knebel Doeberitz M:
Differential methylation of E2 binding sites in episomal and
integrated HPV 16 genomes in preinvasive and invasive cervical
lesions. Int J Cancer. 132:2087–2094. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Alp Avcı G: Genomic organization and
proteins of human papillomavirus. Mikrobiyol Bul. 46:507–515.
2012.(In Turkish). PubMed/NCBI
|
|
19
|
Akagi K, Li J, Broutian TR, Padilla-Nash
H, Xiao W, Jiang B, Rocco JW, Teknos TN, Kumar B, Wangsa D, et al:
Genome-wide analysis of HPV integration in human cancers reveals
recurrent, focal genomic instability. Genome Res. 24:185–199. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Raybould R, Fiander A, Wilkinson GW and
Hibbitts S: HPV integration detection in CaSki and SiHa using
detection of integrated papillomavirus sequences and
restriction-site PCR. J Virol Methods. 206:51–54. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Klaes R, Woerner SM, Ridder R, Wentzensen
N, Duerst M, Schneider A, Lotz B, Melsheimer P and von Knebel
Doeberitz M: Dectection of High-Risk cervical intraepithelial
neoplasia and cervical cancer by amplification of transcripts
derived from integrated papillomavirus oncogenes. Cancer Res.
59:6132–6136. 1999.PubMed/NCBI
|
|
22
|
Karlsen F, Kalantari M, Jenkins A,
Pettersen E, Kristensen G, Holm R, Johansson B and Hagmar B: Use of
Multiple PCR Sets for Optimal Detection of Human papillomavirus. J
Clin Microbiol. 34:2095–2100. 1996.PubMed/NCBI
|
|
23
|
Hillemanns P and Wang XL: Integration of
HPV-16 and HPV-18 DNA in vulvar intraepithelial neoplasia. Gynecol
Oncol. 100:276–282. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Klimov E, Vinokourova S, Moisjak E,
Rakhmanaliev E, Kobseva V, Laimins L, Kisseljov F and Sulimova G:
Human papilloma viruses and cervical tumours: Mapping of
integration sites and analysis of adjacent cellular sequences. BMC
Cancer. 2:242002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ok Atılgan A, Tepeoğlu M, Haberal AN,
Durukan E, Kuşcu E and Haberal M: Papanicolaou smear findings in
solid-organ transplant recipients compared with normal subjects
according to the Bethesda 2001 system. Exp Clin Transplant. 13
Suppl 1:S219–S222. 2015.
|
|
26
|
Al-Kadri HM, Kamal M, Bamuhair SS, Omair
AA and Bamefleh HS: Prevalence and characteristics of abnormal
Papanicolaou smear in Central Saudi Arabia. Saudi Med J.
36:117–122. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Psifidi A, Dovas CI and Banos G: A
comparison of six methods for genomic DNA extraction suitable for
PCR-based genotypingapplications using ovine milk samples. Mol Cell
Probes. 24:93–98. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Psifidi A, Dovas CI, Bramis G, Lazou T,
Russel CL, Arsenos G and Banos G: Comparison of eleven methods for
genomic DNA extraction suitable for large-scale whole-genome
genotyping and long-Term DNA banking using blood samples. PLoS One.
10:e01159602015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim ST, Chun JW, Park G and Koh JW:
Comparative quantification of plasma TDRD7 mRNA in cataract
patients by real-time polymerase chain reaction. Korean J
Ophthalmol. 28:343–350. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yuan B, Li XY, Zhu T, Yuan L, Hu JP, Chen
J, Gao W and Ren WZ: Antibody study in canine distemper virus
nucleocapsid protein gene-immunized mice. Genet Mol Res.
14:3098–3105. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Das P, Thomas A, Kannan S, Deodhar K,
Shrivastava SK, Mahantshetty U and Mulherkar R: Human
papillomavirus (HPV) genome status & cervical cancer outcome-A
retrospective study. Indian J Med Res. 142:525–532. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Onyekwuluje JM, Steinau M, Swan DC and
Unger ER: A real-time PCR assay for HPV52 detection and viral load
quantification. Clin Lab. 58:61–66. 2012.PubMed/NCBI
|
|
34
|
Ardhaoui M, Ennaifer E, Letaief H,
Salsabil R, Lassili T, Chahed K, Bougatef S, Bahrini A, El Fehri E,
Ouerhani K, et al: Prevalence, genotype distribution and risk
factors for cervical human papillomavirus infection in the grand
tunis region, Tunisia. PLoS One. 11:e01574322016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Salehi-Vaziri M, Sadeghi F,
Bokharaei-Salim F, Younesi S, Alinaghi S, Monavari SH and Keyvani
H: The prevalence and genotype distribution of human papillomavirus
in the genital tract of males in Iran. Jundishapur J Microbiol.
8:e219122015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ewaisha R, Meshay I, Resnik J, Katchman BA
and Anderson KS: Programmable protein arrays for immunoprofiling
HPV-associated cancers. Proteomics. 16:1215–1224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Castle PE, Schiffman M, Scott DR, Sherman
ME, Glass AG, Rush BB, Schussler JE, Wacholder S and Lorincz AT:
Semiquantitative human papillomavirus type 16 viral load and the
prospective risk of cervicalprecancer and cancer. Cancer Epidemiol
Biomarkers Prev. 14:1311–1314. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shukla S, Mahata S, Shishodia G, Pande S,
Verma G, Hedau S, Bhambhani S, Kumari A, Batra S, Basir SF, et al:
Physical state & copy number of high risk human papillomavirus
type 16 DNA in progression of cervical cancer. Indian J Med Res.
139:531–543. 2014.PubMed/NCBI
|
|
39
|
Wentzensen N, Gravitt PE, Long R,
Schiffman M, Dunn ST, Carreon JD, Allen RA, Gunja M, Zuna RE,
Sherman ME, et al: Human papillomavirus load measured by Linear
Array correlates with quantitative PCR in cervical cytology
specimens. J Clin Microbiol. 50:1564–1570. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Theelen W, Reijans M, Simons G, Ramaekers
FC, Speel EJ and Hopman AH: A new multiparameter assay to assess
HPV 16/18, viral load and physical status together with gain of
telomerase genes in HPV-related cancers. Int J Cancer. 126:959–975.
2010.PubMed/NCBI
|
|
41
|
Jacobs MV, Walboomers JM, van Beek J,
Voorhorst FJ, Verheijen RH, Meijer CJ, van den Brule AJ,
Helmerhorst TJ and Snijders PJ: A quantitative polymerase chain
reaction-enzyme immunoassay for accurate measurements of human
papillomavirus type 16 DNA levels in cervical scrapings. Br J
Cancer. 81:114–121. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Constandinou-Williams C, Collins SI,
Roberts S, Young LS, Woodman CB and Murray PG: Is human
papillomavirus viral load a clinically useful predictive marker? A
longitudinal study. Cancer Epidemiol Biomarkers Prev. 19:832–837.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zhang R, He YF, Chen M, Chen CM, Zhu QJ,
Lu H, Wei ZH, Li F, Zhang XX, Xu CJ and Yu L: Diagnosis of 25
genotypes of human papillomaviruses for their physical statuses in
cervical precancerous/cancerous lesions: a comparison of E2/E6E7
ratio-based vs. Multiple E1-L1/E6E7 ratio-based detection
techniques. J Transl Med. 12:2822014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kadaja M, Sumerina A, Verst T, Ojarand M,
Ustav E and Ustav M: Genomic instability of the host cell induced
by the human papillomavirus replication machinery. EMBO J.
26:2180–2191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Johansson C, Somberg M, Li X, Winquist
Backström E, Fay J, Ryan F, Pim D, Banks L and Schwartz S: HPV-16
E2 contributes to induction of HPV-16 late gene expression by
inhibiting early polyadenylation. EMBO J. 31:3212–3227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Al-Shabanah OA, Hafez MM, Hassan ZK,
Sayed-Ahmed MM, Abozeed WN, Al-Rejaie SS and Alsheikh AA: Human
papillomavirus genotyping and integration in ovarian cancer Saudi
patients. Virol J. 10:3432013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Das P, Thomas A, Mahantshetty U,
Shrivastava SK, Deodhar K and Mulherkar R: HPV genotyping and site
of viral integration in cervical cancers in Indian women. PLoS One.
7:e410122012. View Article : Google Scholar : PubMed/NCBI
|
